Results 161 to 170 of about 25,840,332 (309)

Using system dynamics to understand barriers to cost reduction

open access: yes, 2000
Thesis (S.M.)--Massachusetts Institute of Technology, System Design & Management Program, 2000.Includes bibliographical references (v. 2, leaves 340-342).by William L.
Blake, William L. (William Lawrence), 1970-
core  

Document Preparation for Electronic Document Management System [PDF]

open access: yesInternational Journal of Academic Research in Business and Social Sciences, 2018
Mohamad Azri Mohamad Radzi   +3 more
openaire   +1 more source

microRNA‐7‐5p and α‐Synuclein SAA Predict Parkinson's Disease Phenoconversion

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corroborate blood neuron‐derived extracellular vesicle (NDEV) alpha‐synuclein (αSyn), the CSF αSyn seed amplification assay (αSyn‐SAA), and blood microRNA‐7‐5p (miR‐7‐5p) as markers for Parkinson's disease (PD) phenoconversion and determine if combining these markers would help select subjects who would be more likely to phenoconvert.
Shayan Zadegan   +4 more
wiley   +1 more source

Direct cost of trabeculectomy in the Brazilian public health system: a micro-costing analysis in a university hospital. [PDF]

open access: yesRev Esc Enferm USP
Cabral JA   +9 more
europepmc   +1 more source

Distortion of "fast clockspeed" product development : using web-based conjoint analysis, clockspeed analysis and technology strategy for an automotive telematics system

open access: yes, 2001
Thesis (S.M.)--Massachusetts Institute of Technology, System Design & Management Program, 2001.Includes bibliographical references (leaves 104-105).by Sean M.
Newell, Sean M. (Sean Michael), 1970-
core  

System Development for Document Management System [PDF]

open access: yesInternational Journal of Academic Research in Business and Social Sciences, 2018
Fatin Hazwani Kiplie   +3 more
openaire   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

[Expansion of access to specialized care: the experience of Regional Health Consortia in Bahia, Brazil]. [PDF]

open access: yesCad Saude Publica
Souza LEPF   +7 more
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

open access: yesArthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos   +2 more
wiley   +1 more source

Health system strategies for adaptation to drought: A global scoping review. [PDF]

open access: yesJ Clim Chang Health
Khosravifar A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy